Parkman Healthcare Partners LLC
Position in XENE — Xenon Pharmaceuticals Inc.
CIK 1777015
STAMFORD, CT
Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,985,796
-$4,916,789 QoQ
Shares Held
397,379
-20.1% QoQ
Ownership
0.410%
of shares outstanding
% of Portfolio
2.49%
of 13F equity value
Holder Rank
#55
of 313 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parkman Healthcare Partners LLC holds $508,391,007 across 37 Biotechnology names. XENE ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MBX |
MBX Biosciences, Inc.
|
800,173 | $44,169,549 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
435,691 | $35,539,314 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
919,266 | $28,340,970 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
485,661 | $26,065,425 | |
| 5 | VRDN |
Viridian Therapeutics, Inc.\DE
|
1,377,576 | $25,306,071 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
669,046 | $24,828,297 | |
| 7 | INBX |
Inhibrx Biosciences, Inc.
|
256,950 | $24,346,012 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
397,379 | $23,985,796 |
All Filings in XENE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,985,796 | 397,379 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $28,902,585 | 497,035 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,910,526 | 154,184 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,071,900 | 176,137 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,706,674 | 150,373 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,857,024 | 174,576 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,565,756 | 193,004 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,545,575 | 191,658 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,160,217 | 209,290 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,640,703 | 223,942 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,577,935 | 294,788 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,400,559 | 216,644 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,382,990 | 217,740 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $9,923,958 | 277,283 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,285,410 | 235,491 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,035,751 | 222,597 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,960,484 | 294,559 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,298,966 | 304,186 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,262,082 | 360,502 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,755,242 | 311,207 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,470,474 | 401,207 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,701,670 | 374,395 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,562,776 | 361,689 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,145,612 | 464,825 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,401,948 | 590,267 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,693,627 | 590,267 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||